# Precipart Corp – FDA Inspection, Dec 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/precipart-corp/8b207fdd-0900-47c2-935b-cbb128a9915b
Source feed: FDA_Inspections

> FDA inspection 1226525 of Precipart Corp, December 20, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226525
- Company Name: Precipart Corp
- Inspection Date: 2023-12-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 0

## Related Documents

- FDA Inspection 1136295 - 2021-02-25
- [FDA Inspection 1041079 - 2018-02-09](https://www.keypedia.com/records/fda_inspections/precipart-corp/51d86fc3-f467-4ee4-acb4-20f8ad94d3e8)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/andrew-j-garufi/567f6aaa-f6f2-45a3-9a58-80b33f3ad021)

Company: https://www.keypedia.com/companies/precipart-corp/23370f3c-d19d-4cd2-9369-c9c780b57c5a

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
